Within Range: Demystifying Diabetes Tech for Healthcare Professionals

Within Range is a podcast for Healthcare Professionals. Diabetes tech innovation moves quickly and it can be challenging to keep all the details about the available AID systems straight. Our new podcast, Within Range: Demystifying Diabetes Tech will help bust some myths and clear up any confusion about the Omnipod® 5 Automated Insulin Delivery System. Co-hosts Cindy Pickering & Kate Neal lead conversations with Healthcare Professionals with varying specialties and backgrounds. From clinical research and guidelines, system details, algorithm functionality, to the more practical aspects of helping people live with T1D, you are invited to listen in, while they cover a variety of specialisms. This professional (but entertaining) podcast aims to navigate the complexities of diabetes technology and increase understanding and confidence to help simplify diabetes management for your patients using the Omnipod 5 Automated Insulin Delivery System.

Within Range: Demystifying Diabetes Tech for Healthcare Professionals is a health podcast hosted by Insulet International, with 22 episodes on record and a Required Pod Score of 80.

Insulet International hosts Within Range: Demystifying Diabetes Tech for Healthcare Professionals, a health show with 22 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Within Range: Demystifying Diabetes Tech for Healthcare Professionals

  From Evidence to Action: The Policy Case for Automated Insulin Delivery

  Sep 22, 202625 min

  This special bonus episode of Within Range is hosted by Suzi Patel, Senior Policy & Public Affairs Manager at Insulet International, who leads a conversation intended for policymakers, payers, and healthcare professionals with an interest in policy, with two leading UK diabetes experts, Dr. Jackie Elliott (Consultant, Sheffield Diabetes Technology Network Committee and Chair of DAFNE), and Professor Partha Kar (Consultant, Portsmouth NHS Trust, and former NHS England National Specialty Advisor for Diabetes). Recorded live at ATTD 2026 in Barcelona. Together they unpack what Automated Insulin Delivery (AID) systems are, why this technology is increasingly recommended by professional societies and health technology assessment bodies for people with type 1 diabetes, and why healthcare systems should view them as a strategic investment rather than a cost. Drawing on the UK's landmark NICE technology appraisal and reflecting on progress of the NHS implementation plan to date, Jackie and Partha discuss the growing body of clinical, quality-of-life, and cost-effectiveness evidence shedding light on how AID systems are transforming care. They also explore the persistent budget-holder barriers slowing adoption in other markets, and the health policy commitments needed to expand equitable access at scale. The episode closes with practical advice for policymakers, payers and health care professionals, on what it will take to make AID systems the standard of care for everyone living with type 1 diabetes. - How can tubeless automated insulin delivery and continuous glucose monitoring help people living with diabetes? Within Range is a podcast for healthcare professionals (HCPs), helping them stay up to date on the latest diabetes innovations. Within Range is presented by Kate Neal and Cindy Pickering (Clinical Services Managers at Insulet) who sit down with diabetes healthcare professionals from acrossthe world to discuss clinical research, best practices and how Omnipod 5 Automated Insulin Delivery systems (AIDs) can help simplify diabetes management for patients with Type 1 diabetes (T1D). Disclaimer: Note: The information in this podcast is accurate to the date of recording as of 12/03/2026. Dr Jackie Elliott and Dr Partha Kar, views and opinions expressed in this podcast are her own and do not necessarily reflect those of Insulet. Omnipod 5 is CE Marked, UKCA marked, Health Canada approved, and TGA approved for use in Type 1 diabetes in people ages 2 years and up. For a complete description of Omnipod 5 including indications, contraindications and important safety information for the UK please visit: https://www.omnipod.com/en-gb/safety. For other regions, please refer to country specific statements at www.omnipod.com. Omnipod 5 may not be available in your country. © Insulet Corporation. All rights reserved. INS-OHS-07-2026 -00007 v1.0

  ListenShow Notes
• 

  Within Range: Demystifying Diabetes Tech for Healthcare Professionals

  Beyond Time in Range: The Impact of Simplicity

  Sep 15, 202619 min

  In this episode of Within Range, host Kate Neal talks with Dr. Bernhard Gehr, Senior Physician at the Diabetes and Metabolic Centre in Bad Heilbrunn, Germany. Dr. Gehr treats some of the most complex diabetes cases in his region and has type 1 diabetes himself giving a unique perspective on the features of Automated Insulin Delivery (AID) Systems that matter most. Dr. Gehr explains why the simplicity of The Omnipod® 5 Automated Insulin Delivery System makes it a strong fit for patients who resisted technology for years, including those who ruled out tubing or found other systems too demanding. He walks through how he sets glucose targets for patients with hypo fear or retinopathy, how the Custom Food feature helps patients who struggle with carb counting, and why bolus timing may matter more than carb accuracy for time in range. He closes with the story of a 43-year-old engineer who avoided pump therapy for years before starting Omnipod 5, and saw better glucose results from his first night on the system. Dr. Gehr uses the patient's progress to underscore that quality of life and ease of use matter just as much as the glucose numbers themselves  How can continuous glucose monitoring and tubeless insulin delivery help people living with diabetes? Within Range is a podcast for healthcare professionals (HCPs), helping them stay up to date on the latest diabetes innovations. ​ Within Range is presented by Kate Neal and Cindy Pickering (Clinical Services Managers at Insulet) who sit down with diabetes healthcare professionals from across the world to discuss clinical research, best practices and how Omnipod 5 Automated Insulin Delivery systems (AIDs) can help simplify diabetes management for patients with Type 1 diabetes (T1D). ​If you’re looking to improve your patient’s time in range as well as time in happiness, then this is the podcast for you. ​ Disclaimer​:  Note: The information in this podcast is accurate to the date of recording as of 12/03/2026. Bernhard Gehr ​was paid for his participation in this podcast, his views and opinions expressed in this podcast are his own and do not necessarily reflect those of Insulet. ​ This Podcast is meant for healthcare professionals to better understand the Omnipod 5 System and its use within​ clinical practice settings. Omnipod 5 is CE Marked, UKCA marked, Health Canada approved, and TGA approved for use​ in Type 1 diabetes in people ages 2 years and up. For a complete description of Omnipod 5 including indications,​contraindications and important safety information for the UK please visit: https://www.omnipod.com/en-gb/safety.  ​ For other regions, please refer to country specific statements at www.omnipod.com. ​Omnipod 5 may not be available in your country.  © Insulet Corporation. All rights reserved. INS-OHS-08-2026-00136 v1.0

  ListenShow Notes
• 

  Within Range: Demystifying Diabetes Tech for Healthcare Professionals

  Beyond Time in Range: The Impact of Simplicity

  Sep 8, 202619 min

  In this episode of Within Range, host Kate Neal talks with Dr. Bernhard Gehr, Senior Physician at the Diabetes and Metabolic Centre in Bad Heilbrunn, Germany. Dr. Gehr treats some of the most complex diabetes cases in his region and has type 1 diabetes himself giving a unique perspective on the features of Automated Insulin Delivery (AID) Systems that matter most. Dr. Gehr explains why the simplicity of The Omnipod® 5 Automated Insulin Delivery System makes it a strong fit for patients who resisted technology for years, including those who ruled out tubing or found other systems too demanding. He walks through how he sets glucose targets for patients with hypo fear or retinopathy, how the Custom Food feature helps patients who struggle with carb counting, and why bolus timing may matter more than carb accuracy for time in range. He closes with the story of a 43-year-old engineer who avoided pump therapy for years before starting Omnipod 5, and saw better glucose results from his first night on the system. Dr. Gehr uses the patient's progress to underscore that quality of life and ease of use matter just as much as the glucose numbers themselves.  -  How can continuous glucose monitoring and tubeless insulin delivery help people living with diabetes? Within Range is a podcast for healthcare professionals (HCPs), helping them stay up to date on the latest diabetes innovations. ​ Within Range is presented by Kate Neal and Cindy Pickering (Clinical Services Managers at Insulet) who sit down with diabetes healthcare professionals from across the world to discuss clinical research, best practices and how Omnipod 5 Automated Insulin Delivery systems (AIDs) can help simplify diabetes management for patients with Type 1 diabetes (T1D). ​If you’re looking to improve your patient’s time in range as well as time in happiness, then this is the podcast for you. ​ Disclaimer​: Note: The information in this podcast is accurate to the date of recording as of 12/03/2026. Bernhard Gehr ​was paid for his participation in this podcast, his views and opinions expressed in this podcast are his own and do not necessarily reflect those of Insulet. ​   This Podcast is meant for healthcare professionals to better understand the Omnipod 5 System and its use within​ clinical practice settings. Omnipod 5 is CE Marked, UKCA marked, Health Canada approved, and TGA approved for use​ in Type 1 diabetes in people ages 2 years and up. For a complete description of Omnipod 5 including indications,​contraindications and important safety information for the UK please visit: https://www.omnipod.com/en gb/safety.  ​   For other regions, please refer to country specific statements at www.omnipod.com. ​ Omnipod 5 may not be available in your country.  © Insulet Corporation. All rights reserved. INS-OHS-08-2026-00136v1.0

  ListenShow Notes
• 

  Within Range: Demystifying Diabetes Tech for Healthcare Professionals

  RADIANT Trial Results: The Impact on Type 1 Diabetes (T1D) Patients and a Glimpse into the Future of Diabetes Care

  Apr 21, 202617 minS0

  <p>What happens when you transition type 1 diabetes (T1D) patients from multiple daily injections (MDI) to Omnipod 5 using Abbott’s Freestyle Libre 2?  That is exactly what the RADIANT Randomized Controlled Trial (RCT) investigated.   </p> <p>Listen to Within Range with Kate Neal, Clinical Services Manager at Insulet who is joined by Dr. Emma Wilmot - Associate Professor at University of Nottingham, consultant Diabetologist, & founder of the Diabetes Technology Network UK - to unpack the incredible results of the RADIANT trial and discuss its impact on patients and the future of diabetes care. </p> <p>Recently published in The Lancet Diabetes & Endocrinology journal, ...

  ListenShow Notes
• 

  Within Range: Demystifying Diabetes Tech for Healthcare Professionals

  REPLAY: Understanding Omnipod 5: The future of Diabetes Tech

  Mar 17, 202630 minS0

  <p>In our inaugural episode, hosts Kate Neal and Cindy Pickering are joined by Dr Sufyan Hussain, consultant in diabetes, endocrinology and general medicine at Guys and St Thomas’s Hospital in London. Dr Hussain talks about his personal and professional experience with type 1 diabetes and how he has seen technology rapidly evolve over the past decade. He discusses his work as a clinician, helping others to manage diabetes with game-changing results through Omnipod® 5 and the approach to training patients on the Omnipod® 5 System in the UK. He provides practical advice to clinicians and sets expectations for patients just starting out...

  ListenShow Notes

Recent guests on Within Range: Demystifying Diabetes Tech for Healthcare Professionals. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.